@article{Vasileiou_E-2022_65546,
title = {Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data},
author = {Vasileiou, E. and Shi, T. and Kerr, S. and Robertson, C. and Joy, M. and Tsang, R. and McGagh, D. and Williams, J. and Hobbs, R. and de Lusignan, S. and Bradley, D. and O'Reilly, D. and Murphy, S. and Chuter, A. and Beggs, J. and Ford, D. and Orton, C. and Akbari, A. and Bedston, S. and Davies, G. and Griffiths, L. and Griffiths, R. and Lowthian, E. and Lyons, J. and Lyons, R. and North, L. and Perry, M. and Torabi, F. and Pickett, J. and McMenamin, J. and McCowan, C. and Agrawal, U. and Wood, R. and Stock, S. and Moore, E. and Henery, P. and Simpson, C. and Sheikh, A.},
month = {feb},
year = {2022},
abstract = {Introduction: The novel coronavirus SARS-CoV-2, which emerged in December 2019, has caused millions of deaths and severe illness worldwide. Numerous vaccines are currently under development of which a few have now been authorised for population-level administration by several countries. As of 20 September 2021, over 48 million people have received their first vaccine dose and over 44 million people have received their second vaccine dose across the UK. We aim to assess the uptake rates, effectiveness, and safety of all currently approved COVID-19 vaccines in the UK.},
volume = {12},
issue = {2},
journal = {BMJ Open},
publisher = {BMJ Publishing Group},
url = {https://doi.org/10.1136/bmjopen-2021-050062},
}
